Chemically synthesized sgRNA offers several key advantages:
(1) Higher editing efficiency: Studies show chemical synthesis achieves higher editing efficiency, compared to IVT sgRNA.
(2) Lower cytotoxicity: IVT sgRNA carries a 5'-triphosphate modification, which can trigger innate immune responses and cytotoxicity. Chemically synthesized sgRNA avoids theses off-target immunostimulatory effects.
(3) Enhanced stability: Chemical synthesis allows the incorporation of stabilizing modifications (e.g., phosphorothioate (PS) bonds and methoxy groups). Moreover, the chemical synthesis process ensures higher batch-to-batch consistency and reproducibility.
(4) Ease of use: Chemically synthesized sgRNA is ready to use upon delivery, while IVT sgRNA requires a multi-step, 2-3 day production process that , incurs greater time and economic costs.



